All data are based on the daily closing price as of September 18, 2025
c

Chong Kun Dang Pharmaceutical

185750.KO
60.58 USD
-1.41
-2.27%

Overview

Last close
60.58 usd
Market cap
798.17M usd
52 week high
90.07 usd
52 week low
48.18 usd
Target price
81.39 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.7024
Price/Book Value
1.2331
Enterprise Value
802.68M usd
EV/Revenue
0.6689
EV/EBITDA
9.5132

Key financials

Revenue TTM
1.20B usd
Gross Profit TTM
374.39M usd
EBITDA TTM
80.73M usd
Earnings per Share
N/A usd
Dividend
0.79 usd
Total assets
1.11B usd
Net debt
44.41M usd

About

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair color medication, as well as insecticides. The company also exports its products. Chong Kun Dang Pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
  • Symbol
    185750.KO
  • Exchange
    KO
  • Isin
    KR7185750007
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Young-Joo Kim
  • Headquarter
    Seoul
  • Web site
    https://www.ckdpharm.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top